HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew S Herbert Selected Research

Epitopes

1/2021Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.
1/2020Development of an antibody cocktail for treatment of Sudan virus infection.
1/2016Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew S Herbert Research Topics

Disease

25Infections
04/2024 - 08/2011
10COVID-19
12/2023 - 01/2020
7Ebola Hemorrhagic Fever
01/2022 - 05/2013
6Vesicular Stomatitis
01/2022 - 09/2017
6Virus Diseases (Viral Diseases)
10/2021 - 04/2009
3Fever (Fevers)
11/2023 - 08/2011
2Crimean Hemorrhagic Fever
03/2024 - 01/2021
2Viremia
07/2021 - 03/2012
2Hantavirus Infections
11/2018 - 06/2015
2Filoviridae Infections
10/2012 - 03/2012
1Weight Loss (Weight Reduction)
11/2023
1Asymptomatic Diseases
11/2023
1Hemorrhagic Fever with Renal Syndrome (HFRS)
01/2022
1Severe Acute Respiratory Syndrome
01/2020
1Critical Illness (Critically Ill)
12/2017
1Communicable Diseases (Infectious Diseases)
01/2016
1Human Influenza (Influenza)
04/2009
1Influenza in Birds (Avian Flu)
04/2009

Drug/Important Bio-Agent (IBA)

11Glycoproteins (Glycoprotein)IBA
03/2024 - 10/2015
9VaccinesIBA
01/2022 - 04/2009
8AntibodiesIBA
03/2024 - 01/2016
8Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2009
7Monoclonal AntibodiesIBA
01/2023 - 05/2017
4Neutralizing AntibodiesIBA
03/2024 - 01/2020
4Antiviral Agents (Antivirals)IBA
07/2021 - 08/2011
3EpitopesIBA
01/2021 - 01/2016
3Immunoglobulin G (IgG)IBA
01/2021 - 03/2012
3Polysaccharides (Glycans)IBA
01/2020 - 09/2017
2Immune Sera (Antisera)IBA
05/2020 - 01/2020
2Broadly Neutralizing AntibodiesIBA
05/2020 - 01/2020
2CholesterolIBA
06/2015 - 05/2015
1Indicators and Reagents (Reagents)IBA
12/2023
1AerosolsIBA
11/2023
1AntigensIBA
10/2022
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2022
1cilgavimab and tixagevimab drug combinationIBA
01/2022
1ProteomeIBA
11/2021
1EnzymesIBA
11/2021
1SARS-CoV-2 spike proteinIBA
10/2021
1nidoviral uridylate-specific endoribonucleaseIBA
10/2021
1Heparin (Liquaemin)FDA LinkGeneric
07/2021
1Combined Antibody TherapeuticsIBA
01/2020
1Angiotensin-Converting Enzyme 2IBA
01/2020
1Viral ProteinsIBA
08/2019
1TetraspaninsIBA
11/2017
1Neuropilin-2IBA
11/2017
1Immunoglobulin M (IgM)IBA
09/2017
1Cysteine (L-Cysteine)FDA Link
03/2016
1CathepsinsIBA
03/2016
1Amino AcidsFDA Link
03/2016
1Virus ReceptorsIBA
12/2015
1Niemann-Pick C1 ProteinIBA
10/2015
1ElementsIBA
06/2015
1Peptide Hydrolases (Proteases)FDA Link
06/2015
1site 1 membrane-bound transcription factor peptidaseIBA
06/2015
1Influenza Vaccines (Influenza Vaccine)FDA Link
04/2009
1Interleukin-2 (IL2)IBA
04/2009

Therapy/Procedure

10Therapeutics
04/2024 - 03/2012
1Investigational Therapies (Experimental Therapy)
12/2017